Intrinsic Value of S&P & Nasdaq Contact Us

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Conformis, Inc. (CFMS) reported total assets of $94.05M and total liabilities of $39.87M for fiscal year 2022, resulting in total equity of $54.18M.

The company held $48.67M in cash and short-term investments. Total debt stood at $27.5M, with net debt of $-21.17M. The Debt-to-Equity (D/E) ratio was 0.51 (moderate).

Current ratio is 5.63, indicating strong short-term liquidity. Interest coverage is -22.9x (weak).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (21/100) — Total assets $94.05M and equity $54.18M support the company's competitive scale

Overall SharesGrow Score: 19/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
21/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Conformis, Inc. Balance Sheet History
Metric FY2022 FY2021 FY2020 FY2019
Total Assets $94.05M$145.34M$71.5M$72.4M
Total Liabilities $39.87M$44.79M$60.13M$56.05M
Total Debt $27.5M$28.66M$30.83M$26.16M
Cash & Investments $48.67M$100.56M$28.67M$26.39M
Total Stockholders Equity $54.18M$100.55M$11.37M$16.35M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message